ClinicalTrials.gg
Sign In

Hyperbilirubinemia, Neonatal clinical trials

The registry lists 96 studies for Hyperbilirubinemia, Neonatal across more than 10 countries. 20 are recruiting or about to start. 63 of them are mainly about Hyperbilirubinemia, Neonatal (how this is decided). Per ClinicalTrials.gov, last updated 2026-09-25. Counting its narrower condition Jaundice, Neonatal too: 177 studies, 39 open.

Get an email when these change. Save the Hyperbilirubinemia, Neonatal studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
55
Recruiting
14
Status unknown
14
Not yet recruiting
5
Active, not recruiting
3
Withdrawn
2

Phase

Phase 4
6
Phase 2
4
Phase 3
3
Early Phase 1
1

Where

Turkey
17
China
12
United States
12
Egypt
5
Norway
3
Netherlands
3

Who runs them

InfaCare Pharmaceuticals Corporation, a Mallinckrodt Company (5) · University of Aarhus (4) · Nanjing Medical University (4) · University of Oxford (3) · National Taiwan University Hospital (2) · University of Patras (2) · St. Olavs Hospital (2) · Karabuk University (2)

What is being tested here

Drugs under test in Hyperbilirubinemia, Neonatal studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Ursodeoxycholic Acid102
Streptococcus thermophilus101
Bifidobacterium breve101
Bifidobacterium animalis subsp. lactis101
Lacteol101
Lactobacillus plantarum101
Lacticaseibacillus paracasei101
Lactobacillus helveticus101
Fenofibrate002
Tin mesoporphyrin002

Coming up

1phase 3 study under way
8studies finish main data collection within a year1 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 8, phase 3 first

Who these studies take

Of the 14 Hyperbilirubinemia, Neonatal studies recruiting now, 0 (0%) set no upper age limit and 14 (100%) stop at 75 or younger. 13 (93%) take children under 18. 1 (7%) are for women only and 0 (0%) for men only; 7 (50%) take healthy volunteers.

Recruiting studies that take each age, of 14
AgeWomenMen
100 (0%)0 (0%)
181 (7%)0 (0%)
301 (7%)0 (0%)
401 (7%)0 (0%)
500 (0%)0 (0%)
650 (0%)0 (0%)
750 (0%)0 (0%)
850 (0%)0 (0%)

Across all 96 studies, recruiting or not: 90% stop at 75 or younger and 90% at 65; 94% take children; 5% are for women only and 0% for men only; 38% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Hyperbilirubinemia, Neonatal studies take

Of 34 interventional studies with no phase under Hyperbilirubinemia, Neonatal, half reached primary completion within 10 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase10 mo6–21 · 34 studies—10 mo6–21 · 34 studies
Observational20 mo6–59 · 15 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

Studies

Recruiting first, then most recently updated. Showing 50 of 96. Browse all 96 → or search them.